e-Pharma & Social...
Follow
7.7K views | +0 today
e-Pharma & Social Media
Your new post is loading...
Your new post is loading...
Scooped by Antoine POIGNANT, MD
Scoop.it!

Formation Marketing santé à l'heure du digital - Organisme de formation professionnelle continue - Les Echos Formation

Formation Marketing santé à l'heure du digital - Organisme de formation professionnelle continue - Les Echos Formation | e-Pharma & Social Media | Scoop.it
La formation Un format unique : training en réel sur IPad !, réalisable aussi en intra-entreprise , vous permettra de - Optimiser sa stratégie digitale et déterminer les facteurs clés de succès : e-patients, promotion, datas, ROI...
- Connaître les meilleures pratiques de e-detailing et de marketing multicanal avec des...
Antoine POIGNANT, MD's insight:

Formation exclusive MEDITAILING LES ECHOS 

Format innovant : iPad prêté

Entièrement interactive : thèmes digital santé et pharma

more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Digital World of Pharma - #Esanté - #Ehealth
Scoop.it!

Novartis Investing in $49 Billion mHealth market - Healthcare Social Media India

Novartis Investing in $49 Billion mHealth market - Healthcare Social Media India | e-Pharma & Social Media | Scoop.it
Novartis currently has 13 iPhone apps in Apple's App Store, and nine of them are designed for patients and consumers. Some, like "Sickel Cell Iron Invaders (Novartis Investing in $49 Billion mHealth...

Via Pharmacomptoir / Corinne Thuderoz
more...
Debbie Irwin's curator insight, September 28, 8:52 AM

It's all about patients as partners....

Scooped by Antoine POIGNANT, MD
Scoop.it!

Le Leem lance la plateforme d’échange Talents de patients

Le Leem lance la plateforme d’échange Talents de patients | e-Pharma & Social Media | Scoop.it
Pour recueillir et rendre visible la diversité des témoignages de patients et leur inventivité, Les Entreprises du Médicament (Leem) ouvre une plateforme d’échange : Talents de patients.
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Buzz e-sante
Scoop.it!

Social Media Rules: The FDA Crackdown

Social Media Rules: The FDA Crackdown | e-Pharma & Social Media | Scoop.it

Studies have shown that 60% of Americans turn to the internet for medical advice. It’s obvious how social media naturally seems like another method pharmaceutical companies can quickly and easily advertise to consumers. Are pharmaceutical companies alone in trying to tap into our unconscious? Would you be surprised if I told you that you could be inadvertently perpetuating such behavior?  

The U.S. is one of the few countries that permits direct-to-consumer advertising of pharmaceuticals. We’ve all see the ads that ramble on about all the potential risks and side effects associated with various medications. No doubt you’ve probably been bombarded with flashy sidebars on the internet promoting one medication or another — some creepily relevant to our own medical conditions. As social media became a part of life for many of us, pharmaceutical companies were quick to exploit the medium. Platforms like Twitter are free to operate and far-reaching. Only until recently has there been a greater effort to regulate the content being disseminated to the public.

In this day and age, Big Pharma might not be quite as cavalier as you might expect. A quick search on Twitter says it all. Almost every major drug company has a verified Twitter account. While companies are generous in providing general medical knowledge or the update here or there that says the company is actively researching condition X, seldom do you find anything plugging a specific product.

Direct-to-consumer advertising on social media has revealed many challenges. Sometimes 140 characters simply isn’t enough to convey all the benefits let alone the black box warnings a drug may possess. The “Twitterverse” is an international community, and messages applicable to one population could wrongfully passed on to another. Some medications banned by one country may be promoted by individuals and corporations of another country. In fact, Glaxo Smith-Kline and AstraZeneca reportedly have disclaimers on their Facebook sites saying that information is “intended for US residents/consumers only.”

But how often are pharmaceutical companies really harping on their own products on Twitter? More likely than not, individuals are weighing in with their micro-reviews on Twitter. Some would argue that these posts could impact consumers. Bad experiences often motivate people to say something. What about the positive reviews? Who is really behind the tweets gushing about Medication XYZ?

So far, individuals aren’t being held accountable for claims they make. Should the FDA as individuals to report their disclosures? Should the FDA be verifying all social media posts that mention a drug? Something tells me there no room in the FDA budget for this. Others would go as far as to argue that this violates the first amendment.

In June 2014, the FDA released suggested guidelines to regulate social media posts by drug companies. Essentially for every post claiming benefit of a certain medication, the FDA is demanding equal reporting of risks and a link to more information to go with it. Sounds impossible to squeeze all that into 140 characters, and perhaps it these guidelines were meant to deter drug companies from using social media altogether to promote their products.

Let’s take a step back to ask ourselves a few questions:

Do you think the FDA is being fair to drug companies, or should we be hearing about the risks/benefits of toilet paper or have the nutrition facts be mandated for a tweet promoting candy bars? Do you think such regulations are resulting in adverse effects by deterring some individuals from learning about some medications? As mentioned earlier, should individuals be subjected to the same rules? Should all our tweets be regulated as potential advertisement for whichever product is mentioned?

To read the other posts in Austin Chiang’s Healthcare & Social Media series, click here.

 


Via Plus91, Rémy TESTON
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Domotique, robotique et objets connectés sur le Net
Scoop.it!

Deux stars de la santé connectée confirment avoir été embauchées par Apple

Deux stars de la santé connectée confirment avoir été embauchées par Apple | e-Pharma & Social Media | Scoop.it
Nous vous en parlions en avril dernier : une rumeur affirmait que Divya Nag, véritable de star montante de 22 ans dans le domaine des objets connectés à destination du domaine médi...

Via Mau
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Laboratoires pharmaceutiques : les défis de la transformation digitale

Laboratoires pharmaceutiques : les défis de la transformation digitale | e-Pharma & Social Media | Scoop.it
Par sa dimension systémique, la révolution numérique induit des bouleversements majeurs au sein des entreprises. Avec la même force de...
Antoine POIGNANT, MD's insight:

Pour les laboratoires pharmaceutiques, au-delà de la “simple” digitalisation des actions et de la relation client, comment -et surtout pourquoi- élaborer une transformation qui ancre véritablement le digital dans toutes les dimensions du modèle d’affaires ? Quels enseignements tirer de secteurs plus « digitalisés » que la pharmacie ou dont le business model a déjà été disrupté ? Quelles sont les meilleures pratiques mises en place par la pharma  ?


Les big techs (Google, Apple, Samsung…) sont-ils vraiment  les futurs leaders mondiaux de la santé ? Quels sont leurs atouts ? Quelles sont leurs avancées stratégiques les plus récentes dans le domaine de la santé digitale ? Pourquoi entrent-ils sur le marché des bio-médicaments ? Comment veulent-ils disrupter le marché de la santé ?

more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Buzz e-sante
Scoop.it!

Apple needs healthcare and medical tech companies to help create reasons to wear their devices

Apple needs healthcare and medical tech companies to help create reasons to wear their devices | e-Pharma & Social Media | Scoop.it

Apple is trying create 'an iPod experience' in healthcare driven by its wearables, but Apple's wearables need to do things significant enough to persuade health consumers to carry their products around with them.


Via Andrew Spong, Rémy TESTON
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Agence TROUBAT
Scoop.it!

Apple's Innovation Secret: Bad Ideas

Apple's Innovation Secret: Bad Ideas | e-Pharma & Social Media | Scoop.it
In the history of bad ideas, becoming a pirate ranks near the top. Pirates rarely die old, and hardly go quietly. Blackbeard, perhaps the most famous Caribbean marauder of the 18th century, died of

Via EuroHealthNet
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Laboratoires pharmaceutiques et transformation digitale #hcsmeufr

Laboratoires pharmaceutiques et transformation digitale #hcsmeufr | e-Pharma & Social Media | Scoop.it
La transformation digitale vecteur de croissance et de création de valeur : web casting, web conference, serious games, apps, flashcodes, santé connectée,
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Pharma Hub
Scoop.it!

Google Fit : la nouvelle plateforme santé de Google

Google Fit : la nouvelle plateforme santé de Google | e-Pharma & Social Media | Scoop.it

 Depuis Internet, il sera bientôt possible de jeter un coup d'oeil sur les données relatifs à sa santé grâce à un nouveau service Google.


Via Philippe Marchal/Pharma Hub
Antoine POIGNANT, MD's insight:

#quantifiedself #google #ehealth

more...
Jim Murphy's curator insight, June 17, 9:42 AM

@Google... êtes-vous sérieux cette fois?

Rescooped by Antoine POIGNANT, MD from Quantified Self, IOT and Technology
Scoop.it!

5 ways to improve the adoption of medical apps

5 ways to improve the adoption of medical apps | e-Pharma & Social Media | Scoop.it

Before the adoption of new technologies which will undoubtedly improve health care (as it has the retail and finance sectors), it must be introduced in ways which are digestible, scalable, and subject to rapid iteration.

Is mobile technology different from the adoption of any other change in health care delivery? I think not. The culture of care certainly requires change as care models are changing. The point of care is shifting to the home, professionals other than physicians are delivering most of the care, and digital technology is becoming a fact of daily life.

 

With this care shift is the shift of daily tasks to mobile technology. Most mobile tools utilized today by physicians is related to reference or other resources geared towards them, not the patient or care. I suggest a few ways in which the introduction of mobile health care tools to physicians will itself lead to adoption. Baby steps are needed in this process contrary to what I see as industry’s “build it and they will come” philosophy, with its predictable disappointment.

The following suggestions are predicated on good medical app development practices.

1. Involve physicians in clinical pilots.  This accomplishes three things. It introduces physicians to mobile health tools and processes involved in using them. It serves an avenue for user experience feedback from both clinicians and patients, and might provide some outcomes data.

2. Establish a network of key opinion leaders (KOLs). Peer to peer education has a successful track record in both the pharma and medical device sectors. The “in the trenches” experience provided by these KOLs is invaluable in conveying information and addressing concerns of physicians.  It speaks to pain points, benefit to patients, and health care and business models.  These KOLs using digital tools themselves via closed professional social networks is a model I would look forward to being useful.  KOLs have impact via presenting data at professional society meetings, discussing new technologies via traditional media outlets as well as social media.

3. Payers incentivizing physicians to use good tools (portal, diabetes tools).  The use of mobile health apps and other tools (communications, delivery of educational content, and interoperability of data with EHR) might promote or even necessitate the use of robust patient portals. This therefore accomplishes two things which will benefit patients. Payers are in the unique position to incentivize both patients and providers to take advantage of these mobile tools. In what way can payers incentivize physicians? How about having a physician directory which spotlights those who utilize mobile health technologies?  Like-minded patients who desire to become more participatory in their care will gravitate towards these providers, thereby potentially fostering good relationships even before they meet.

4. Patients introducing technology. Changing behavior in the doctor-patient relationship can be a bidirectional process. Just as physicians can change patient behavior, patients can exert influence as consumers on physicians by asking questions about the use of digital technologies by their physicians. These inquiries might get physicians thinking. Patients who suggest medications based on DTC marketing ads often receive them. Patients who are proactive are better patients.

5. Medical school courses for students. Digital natives (or close to them) are now medical students. There is much enthusiasm by students for the use of mobile technologies in health care.  Many are designing apps or anxious for others to do so. There are many reasons why medical schools are at the forefront of mobile medical apps. A “bottom up” approach seems logical  in this arena because of the slow pace of the change in health care culture by the establishment. Mentors in medical school might not be champions of mobile health tools for many reasons. As often is the case in politics of many sectors of society, the new generation is the source of execution of the dreams of others.

Though none of these points are revolutionary, they should provide sources of consideration for starting points of those interested in this sector. There needs to be a distinction made between introduction and adoption of technology, as I believe they are considerably different. Thinking about the process this way might result in less frustration by the industry, investors, and create a different model for implementation and sales.

 


Via Plus91, François Recorbet
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from NTIC et Santé
Scoop.it!

Le smartphone vous protège des burn-out

Le smartphone vous protège des burn-out | e-Pharma & Social Media | Scoop.it

La technologie ne constitue pas toujours un risque supplémentaire de burn-out dans un monde ultra-connecté. Au contraire même. Soma Analytics, une application sur smartphone, promet aux salariés d'auto-diagnostiquer leur propension à tomber bientôt en situation d'épuisement professionnel.

Détecter les burn-out, il y a une app pour ça !

Quatre étudiants munichoix, lauréats du jury Netexplo 2014*, ont imaginé ce système de tracking en s'appuyant sur diverses données enregistrées tout au long de la journée, au bureau comme à la maison. « Sur plusieurs jours, le temps de sommeil des salariés ou encore la fréquence à laquelle les collaborateurs d'une société font des fautes de frappe sont relevés par les capteurs du smartphone », décrit l'un des co-fondateurs, Johan Huber. Le timbre de la voix est aussi une donnée révélatrice et signe de fatigue professionnelle : il est étudié et modélisé par l'application pendant les appels téléphoniques.

Les données sont ensuite analysées selon une grille de lecture élaborée en collaboration avec des spécialistes du stress, des experts du sommeil, des psychiatres et des psychologues. Si le risque de burn-out est imminent, l'application alerte le salarié : c'est le moment de lever le pied !

Quantified self en entreprise

Soma Analytics est destiné à être un service vendu aux entreprises pour qu'elle le proposent à leurs collaborateurs. Johan Huber ne veut pas citer de noms mais affirme que des cabinets d'avocats sont déjà clients. « Les salariés acceptent-ils d'être ainsi surveillés par un outil préconisé par leur employeur ? », se demande le laboratoire Netexplo (ses membres sont indépendants du jury). Précision rassurante, les données enregistrées par l'application ne sont pas communiquées à l'entreprise. Certes, mais elles sont conservées par Soma...

L'application offre aussi la possibilité pour les salariés d'auto-mesurer leur stress, par exemple avant une présentation devant son patron. Le quantified self, en français la mesure de soi, séduit les développeurs de logiciels. Un autre système, Simsensei, lauréat lui aussi de Netexplo 2014, présente aux utilisateurs un psychologue sous forme d'avatar. La discussion avec ce vrai-faux psychologue n'a que peu d'intérêt. Ce qui compte, c'est l'analyse des 66 points d'expression faciale qui trahissent l'état d'anxiété des individus ainsi scrutés pendant l'échange homme-ordinateur. Une caméra Kinect, développée à l'origine par Microsoft pour l'univers du jeu vidéo, enregistre les données et les transmet au logiciel. Qui lui aussi livre un diagnostique. Une précision tout de même : dans le domaine de l'équilibre mental, l'obsession de mesurer en permanence son stress est déjà un symptôme dépressif…

En savoir plus sur Netexplo 2014* Pendant trois jours, jusqu'au vendredi 28 février, le Forum Netexplo présente le meilleur d'une année d'observation de l'innovation numérique internationale  : Suivez l'évènement en direct A lire aussi  : Cinq innovations qui annoncent l'Internet du futur

Via Rémy TESTON, TUPINIER Arnaud, dbtmobile
Antoine POIGNANT, MD's insight:

#quantifiedself

#burnout

more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Google Glass, Google chic

Google Glass, Google chic | e-Pharma & Social Media | Scoop.it
Antoine POIGNANT, MD's insight:
Google vient d’annoncer avoir signé un partenariat avec Luxottica, sur son projet Google Glass. Les marques Oakley et Ray-Ban sont évoquées.
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Mobile Health: How Mobile Phones Support Health Care
Scoop.it!

Five Expectations For Physicians About The Future of Medicine

Five Expectations For Physicians About The Future of Medicine | e-Pharma & Social Media | Scoop.it

Five Expectations For Physicians About The Future of Medicineby Bertalan Meskó (MD, PhD) on September 25, 2014

The waves of technological changes coming towards us will generate new possibilities as well as serious threats to medicine and healthcare. Every stakeholder must prepare for these changes in order to reach a balance between using disruptive technologies in medicine and keeping the human touch.

I remain confident that it is still possible to establish that balance and there are reasons not only for patients but also for physicians to look forward to the next few years in medicine. Here are 5 of them.

 

1) Finally focus on patients

Technology is not against physicians and algorithms are not designed to replace them. Instead, by using efficient and simple technologies in the practice, physicians will finally have time and energy to focus on the patients.

Looking into their eyes while inputting data with augmented reality (Google Glass or digital contact lenses); listening to patients instead of trying to find the right information (as IBM Watson provides that already); and having access to all the devices that are needed to provide a good care (smartphones serving as biosensor packages). What is it if not a great prospect?

 

2) Avoid burning out

With supercomputers being used in medical decision making; physicians having skills related to digital literacy; using intuitive IT solutions that make it simple to input, export and move around data just like how children today use touchscreen devices; and getting access to the medical information they actually need, hours can be saved every week.

With less effort and time, they will be able to provide more care for their patients. This way, patient reward becomes an essential part again in the process of practicing medicine helping caregivers avoid burning out.

 

3) Use data that patients collect

The wearable revolution in health peaking this year gives patients the chance to take care of their own health, thus measure health parameters that have only been available and accessible in the ivory tower of medicine.

By bringing this data to the doctor visit, they can save time and effort, moreover, a true partnership between them can be established. As devices become better, cheaper and more efficient, physicians can soon start encouraging their patients to measure parameters relevant to their health and the results will be discussed and used during the next visit.

 

4) Crowdsource, crowdfund and crowdsolve

With the advances of social media and technologies that give access to these channels, no medical professional should feel alone when dealing with a complicated medical problem of challenge.

If information is needed, it can be crowdsourced; if funding is needed for a new project; it can be crowdfunded; and when a real medical solution is needed, they can find that through an inter-connected network of experts, resources and services.

 

5) Share responsibility with patients

Although it is now the responsibility of physicians to become the guides for their patients online (that requires new skills), by empowering them, actually responsibility can finally be shared. Medical professionals don’t have to make decisions alone, but in a close partnership with the patient.

But for this, every stakeholder must start preparing in time.


Via Emmanuel Capitaine , Celine Sportisse, dbtmobile
more...
Jerome Leleu's curator insight, September 30, 2:02 AM

ajouter votre point de vue ...

Scooped by Antoine POIGNANT, MD
Scoop.it!

Novartis named digital pharma company of the year - PMLiVE

Novartis named digital pharma company of the year - PMLiVE | e-Pharma & Social Media | Scoop.it
Antoine POIGNANT, MD's insight:

#digiitalpride #novartis

more...
EuroHealthNet's curator insight, September 26, 11:59 AM

#novartis #digitalpride #digital

Scooped by Antoine POIGNANT, MD
Scoop.it!

E-santé : une lenteur de déploiement inquiétante.

E-santé : une lenteur de déploiement inquiétante. | e-Pharma & Social Media | Scoop.it
La lenteur du déploiement de la e- Santé en France devient inquiétante, alors que les impératifs économiques sont déjà là. La digitalisation de la santé est pourtant certainement l’une des solutions les plus radicales à cette hémorragie financière.
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Ma santé et le digital francophone
Scoop.it!

Is the Healthcare Industry Digitally Fit? Our Survey #hcsmeu

Digital technologies are altering the very fabric of the traditional healthcare delivery model. Consumers are actively embracing digital tools to take charge o…

Via Plus91, Lionel Reichardt / le Pharmageek, Emmanuel Capitaine
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Digitized Health
Scoop.it!

Home - Open Health

Home - Open Health | e-Pharma & Social Media | Scoop.it
Mobile Health Application In A Week! Start!

Via Emmanuel Capitaine
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from le monde de la e-santé
Scoop.it!

Bayer’s Digital Health Accelerator Picks 5 Startups

Bayer’s Digital Health Accelerator Picks 5 Startups | e-Pharma & Social Media | Scoop.it
The pharmaceutical company grants valuable mentoring and $65,000 in seed money to each of the five companies, and gets up to 10 percent equity in return.

Via TUPINIER Arnaud, Lionel Reichardt / le Pharmageek, Jérôme Buisson, Fabrice Vezin
more...
Bettina Gifford's curator insight, September 9, 5:44 PM

Bayer and Merck leading the way?

Rescooped by Antoine POIGNANT, MD from le monde de la e-santé
Scoop.it!

Vade-mecum Télémédecine

Vade-mecum Télémédecine | e-Pharma & Social Media | Scoop.it
Le @CNOM édite un Vade-mecum : guide commenté pour la construction et la pratique de projets de #télémédecine. http://t.co/V9kboQRN2s

Via Emmanuel Capitaine , Fabrice Vezin
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Laboratoires pharmaceutiques et transformation digitale [étude]

Laboratoires pharmaceutiques et transformation digitale [étude] | e-Pharma & Social Media | Scoop.it

La transformation digitale est un vecteur de croissance et de création de valeur : web casting, web conference, serious games, apps, flashcodes, santé connectée, nouvel écosystème ...

Antoine POIGNANT, MD's insight:

La révolution numérique, en faisant entrer la société toute entière dans l’ère de l’information ubiquitaire,

induit des bouleversements majeurs au sein des entreprises. Avec la même force de disruption que la

révolution industrielle, elle transforme leur modèle d’affaires, leurs organisations, leur culture et leur mode

de management.

more...
EuroHealthNet's curator insight, September 6, 12:36 AM

Les big techs futurs géants de la pharma ?


Un membre du conseil d'administration du groupe suisse Roche vient ainsi de quitter ses fonctions pour se concentrer sur son poste de PDG de Calico, la société de Google dans la santé, qui vient tout juste d'annoncer son premier investissement en partenariat avec la société de biotechnologie AbbVie.


Novartis mène un partenariat avec Google pour une lentille cornéenne connectée qui mesure la glycémie...


Découvrez l'étude MEDITAILING / LES ECHOS ETUDES entièrement consacrée à la transformation digitales des laboratoires pharmaceutiques.

Rescooped by Antoine POIGNANT, MD from actualité pharma-biotech-santé
Scoop.it!

Biopharmaceutical Industry Consolidation Diminishes Future Drug Discovery

Biopharmaceutical Industry Consolidation Diminishes Future Drug Discovery | e-Pharma & Social Media | Scoop.it
Literally dozens of pharmaceutical companies have disappeared over the last 20 years, not just small companies, but major ones like Upjohn, Pharmacia, Searle, Warner-Lambert and Schering-Plough. They have disappeared for excellent business reasons. But as a result, at a time when there is an explosion in the understanding of the cause of diseases, industry contraction has resulted in fewer scientists pursuing these new insights. In the long term, that doesn’t benefit the world’s health.

Via Richard Meyer, Robert Courbé, Julia FRANCOIS-BOUET
Antoine POIGNANT, MD's insight:

En même temps on s'en doutait un peu, la finance ne fait pas l'invasion, l'inverse ?

#astrazeneca vs #pfizer

more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Ce qui se dit sur l'hôpital et la santé en France... et ailleurs
Scoop.it!

Furieux du plan d’économies sur le médicament, le LEEM claque la porte du conseil stratégique des industries de santé | Le Quotidien du Medecin

Furieux du plan d’économies sur le médicament, le LEEM claque la porte du conseil stratégique des industries de santé | Le Quotidien du Medecin | e-Pharma & Social Media | Scoop.it

Via Pharmacomptoir / Corinne Thuderoz, E. Lacoste-Mbaye
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Quantified Self, IOT and Technology
Scoop.it!

Top Physician Information Sources by Mobile Device

Top Physician Information Sources by Mobile Device | e-Pharma & Social Media | Scoop.it

The infographic above illustrates the top physician information sources by frequency of mobile device usage on smartphones/tablets. 

 

source: http://hitconsultant.net/2014/02/20/infographic-top-physician-information-sources-mobile-device/

 


Via nrip, François Recorbet
Antoine POIGNANT, MD's insight:

The infographic above illustrates the top physician information sources by frequency of mobile device usage on smartphones/tablets. 

more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from le monde de la e-santé
Scoop.it!

Toshiba crée une filiale dédiée à la santé, jugée activité stratégique

Toshiba crée une filiale dédiée à la santé, jugée activité stratégique | e-Pharma & Social Media | Scoop.it
Le conglomérat japonais Toshiba a annoncé jeudi la création prochaine d'une filiale dédiée aux produits et services de santé regroupant ses...

Via Rémy TESTON, Celine Sportisse, Fabrice Vezin
Antoine POIGNANT, MD's insight:

sante + digital = innovation

more...
Romain DEFOY's curator insight, March 29, 4:35 AM

Le groupe va donc établir le 1er juillet une nouvelle entité "santé et soins" qui devrait employer quelque 9.000 personnes.
Elle regroupera entre autres les activités aujourd'hui dispersées d'imagerie radiographique, de systèmes d'analyse génétique et de divers appareillages de diagnostic.